ARCHIVES

Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors

This article is from The Cancer Letter archive.

Vol. 18 No. 20 | May 15, 1992

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines Draft

June 13, 1980

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants

February 13, 1998